(Q35182095)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12873287%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

review article

1 reference

title

The renin-angiotensin system and the long-term complications of diabetes: pathophysiological and therapeutic considerations (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12873287%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

Jennifer L Wilkinson-Berka

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12873287%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

author name string

R E Gilbert

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12873287%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

H Krum

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12873287%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

D J Kelly

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12873287%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

publication date

1 August 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12873287%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12873287%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12873287%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12873287%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

607-621

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12873287%20AND%20SRC:MED&resulttype=core&format=json

Treatment of diabetic retinopathy

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00979.X

Effect of the ACE inhibitor lisinopril on mortality in diabetic patients with acute myocardial infarction: data from the GISSI-3 study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00979.X

Angiotensin AT(1) and AT(2) receptors differentially regulate angiopoietin-2 and vascular endothelial growth factor expression and angiogenesis by modulating heparin binding-epidermal growth factor (EGF)-mediated EGF receptor transactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00979.X

Interactions of transforming growth factor-beta and angiotensin II in renal fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00979.X

Vascular trauma induces rapid but transient mobilization of VEGFR2(+)AC133(+) endothelial precursor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00979.X

Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00979.X

Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00979.X

Pathological expression of renin and angiotensin II in the renal tubule after subtotal nephrectomy. Implications for the pathogenesis of tubulointerstitial fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00979.X

Molecular mechanisms of glucose action on angiotensinogen gene expression in rat proximal tubular cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00979.X

Podocyte foot process broadening in experimental diabetic nephropathy: amelioration with renin-angiotensin blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00979.X

Proteinuria and the expression of the podocyte slit diaphragm protein, nephrin, in diabetic nephropathy: effects of angiotensin converting enzyme inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00979.X

Expression of the slit-diaphragm protein, nephrin, in experimental diabetic nephropathy: differing effects of anti-proteinuric therapies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00979.X

The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria. North American Microalbuminuria Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00979.X

Randomised controlled trial of long term efficacy of captopril on preservation of kidney function in normotensive patients with insulin dependent diabetes and microalbuminuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00979.X

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00979.X

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00979.X

Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00979.X

Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. A 7-year follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00979.X

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00979.X

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00979.X

Effect of subclinical infection on maintaining immunity against measles in vaccinated children in West Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00979.X

Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00979.X

Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00979.X

Use of enalapril to attenuate decline in renal function in normotensive, normoalbuminuric patients with type 2 diabetes mellitus. A randomized, controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00979.X

Reversal of lesions of diabetic nephropathy after pancreas transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00979.X

The cardiac renin-angiotensin system: conceptual, or a regulator of cardiac function?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00979.X

Is there a local renin-angiotensin system in the heart?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00979.X

Role of diabetes in congestive heart failure: the Framingham study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00979.X

Diabetes mellitus and congestive heart failure. Further knowledge needed

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00979.X

A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00979.X

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00979.X

Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00979.X

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00979.X

Effect of carvedilol on survival in severe chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00979.X

Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00979.X

AT(1) receptor blockade and atherosclerosis : hopeful insights into vascular protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00979.X

Angiotensin II induces monocyte chemoattractant protein-1 gene expression in rat vascular smooth muscle cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00979.X

Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00979.X

The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00979.X

Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00979.X

STOP-Hypertension-2 and best practice for the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00979.X

Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00979.X

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00979.X

Rationale and design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). ALLHAT Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00979.X

The interaction between the renin-angiotensin system and vascular endothelial growth factor in the pathogenesis of retinal neovascularization in diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00979.X

Angiotensinogen and its cleaved derivatives inhibit angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00979.X

Modulation of the renin-angiotensin system and retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00979.X

Comparison of candesartan, enalapril, and their combination in congestive heart failure: randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study. The RESOLVD Pilot Study Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00979.X

Upregulation of endothelial receptor for oxidized low-density lipoprotein (LOX-1) in cultured human coronary artery endothelial cells by angiotensin II type 1 receptor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00979.X

Pathophysiology of Progressive Nephropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00979.X

Angiotensin II antagonists for hypertension: are there differences in efficacy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00979.X

Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.00979.X

10.1046/J.1464-5491.2003.00979.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12873287%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference